Astex - PDFSEARCH.IO - Document Search Engine

Astex
Results: 79

#	Item
21	Astex Achieves Milestones in GSK Collaboration Cambridge, UK, 3rd May[removed]Astex Therapeutics, the UK-based biotechnology company developing targeted therapies for oncology and virology, announced that it has achieved m Add to Reading List Source URL: astx.com Language: English Astex GlaxoSmithKline Technology
22	October 11, 2013 Otsuka Pharmaceutical Completes Acquisition of Astex Pharmaceuticals TOKYO--(BUSINESS WIRE)-- Otsuka Holdings Co., Ltd. ("Otsuka Holdings") announced today that its wholly-owned subsidiary, Otsuka Pharm Add to Reading List Source URL: astx.com Language: English Corporate finance Tender offer Otsuka Pharmaceutical
23	September 4, 2012 Astex Pharmaceuticals to Participate on Epigenetics Panel at Rodman & Renshaw Conference DUBLIN, Calif., Sept. 4, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical co Add to Reading List Source URL: astx.com Language: English
24	December 10, 2012 Astex Pharmaceuticals Announces Results From Dose Escalation Part of SGI-110 Phase 1/2 MDS and AML Study in an Oral Presentation at ASH DUBLIN, Calif., Dec. 10, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceu Add to Reading List Source URL: astx.com Language: English Acute leukemia Acute myeloid leukemia Myeloid leukemia Design of experiments Myelodysplastic syndrome Clinical trial Medicine Health Clinical research
25	Astex Therapeutics and Cambridge Crystallographic Data Centre Extend 10-Year Research Collaboration Cambridge, UK, 12th May[removed]Astex Therapeutics, the fragment-based drug discovery company, and the Cambridge Crystallo Add to Reading List Source URL: astx.com Language: English Medicinal chemistry Drug discovery Computational chemistry Molecular modelling Cheminformatics Astex Cambridge Crystallographic Data Centre Protein–ligand docking Docking Pharmaceutical sciences Chemistry Science
26	Encouraging Data on Astex’s Anti-Cancer Drug AT9283 to be Presented at ASH New Data Suggest a Potential Role for AT9283 in Combination With Lenalidomide and With Docetaxel in the Treatment of Multiple Myeloma and Non-H Add to Reading List Source URL: astx.com Language: English Protein kinase inhibitors Tyrosine kinases Immunosuppressants Lenalidomide Orphan drugs CD135 Multiple myeloma Targeted therapy Aurora inhibitor Biology Chemistry Cell biology
27	News Release Astex Pharmaceuticals Reports 2013 Second Quarter Financial Results SGI-110 clinical data presented at EHA for Phase 1 MDS patients Second quarter royalty revenue increased 15% to $16.6 million Royalty reven Add to Reading List Source URL: astx.com Language: English Business Taxation Financial statements Income tax in the United States Financial ratio Balance sheet Royalties Tax Net income Accountancy Finance Generally Accepted Accounting Principles
28	April 22, 2013 Astex Pharmaceuticals to Announce 2013 First Quarter Financial Results on April 29th DUBLIN, Calif., April 22, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company Add to Reading List Source URL: astx.com Language: English
29	October 29, 2012 Astex Pharmaceuticals, Cancer Research Technology and Newcastle University Sign Strategic Drug Discovery Alliance DUBLIN, Calif. and CAMBRIDGE, U.K., Oct. 29, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceutic Add to Reading List Source URL: astx.com Language: English Clinical research Pharmaceutical industry Pharmacology Astex Cancer research Drug discovery Medical research Clinical trial Pharmaceutical sciences Health Research
30	Astex Pharmaceuticals to Present a Novel Targeted Approach to the Treatment of HCV at the AASLD Meeting DUBLIN, Calif.--(BUSINESS WIRE)-- Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), a pharmaceutical company dedicated to t Add to Reading List Source URL: astx.com Language: English Antiviral drug Astex Hepatitis C virus Allosteric regulation

UPDATE